Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.
Natalie J DelRoccoMignon L LohM J BorowitzS GuptaKaren R RabinP Zweidler-McKayK W MaloneyLeonard A MattanoE LarsenA AngiolilloReuven J SchoreMichael J BurkeW L SalzerB L WoodAndrew J CarrollN A HeeremaS C ReshmiJ M Gastier-FosterR HarveyI M ChenKathryn G RobertsCharles G MullighanC WillmanNaomi J WinickWilliam L CarrollR E RauDavid Trent TeacheyS P HungerElizabeth A RaetzMeenakshi DevidasJ A KairallaPublished in: Leukemia (2024)
Current strategies to treat pediatric acute lymphoblastic leukemia rely on risk stratification algorithms using categorical data. We investigated whether using continuous variables assigned different weights would improve risk stratification. We developed and validated a multivariable Cox model for relapse-free survival (RFS) using information from 21199 patients. We constructed risk groups by identifying cutoffs of the COG Prognostic Index (PI COG ) that maximized discrimination of the predictive model. Patients with higher PI COG have higher predicted relapse risk. The PI COG reliably discriminates patients with low vs. high relapse risk. For those with moderate relapse risk using current COG risk classification, the PI COG identifies subgroups with varying 5-year RFS. Among current COG standard-risk average patients, PI COG identifies low and intermediate risk groups with 96% and 90% RFS, respectively. Similarly, amongst current COG high-risk patients, PI COG identifies four groups ranging from 96% to 66% RFS, providing additional discrimination for future treatment stratification. When coupled with traditional algorithms, the novel PI COG can more accurately risk stratify patients, identifying groups with better outcomes who may benefit from less intensive therapy, and those who have high relapse risk needing innovative approaches for cure.
Keyphrases
- end stage renal disease
- young adults
- acute lymphoblastic leukemia
- free survival
- chronic kidney disease
- newly diagnosed
- ejection fraction
- type diabetes
- palliative care
- adipose tissue
- genome wide
- mesenchymal stem cells
- patient reported outcomes
- artificial intelligence
- insulin resistance
- high intensity
- big data
- allogeneic hematopoietic stem cell transplantation
- atomic force microscopy
- single molecule
- combination therapy